Impact Biomedical (IBO) EBIT (2022 - 2026)
Impact Biomedical (IBO) posted EBIT of -$2.3 million for Q1 2026, down 141.46% on a QoQ basis from -$948000.0 in Q3 2025, and down 126.63% year-over-year from $8.6 million in Q1 2025.
Impact Biomedical (IBO) EBIT (2022 - 2026) Analysis & Trends
Impact Biomedical's EBIT history runs 5 years deep, the most recent figure standing at -$2.3 million for Q1 2026.
- Quarterly EBIT fell 126.63% year-over-year to -$2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.4 million (up 81.38% YoY) and the FY2024 annual result came in at -$28.8 million, down 613.83% from the prior year.
- EBIT was -$2.3 million for Q1 2026 at Impact Biomedical, down from -$948000.0 in the prior quarter.
- Across five years, EBIT topped out at -$626000.0 in Q2 2024 and bottomed at -$26.2 million in Q4 2024.
- A 5-year average of -$2.7 million and a median of -$1.0 million in 2025 frame the typical range for EBIT.
- Peak annual rise in EBIT reached 37.9% in 2024, while the deepest fall reached 2202.99% in 2024.
- Impact Biomedical's EBIT stood at -$1.0 million in 2022, then slipped by 10.37% to -$1.1 million in 2023, then slumped by 2202.99% to -$26.2 million in 2024, then surged by 96.39% to -$948000.0 in 2025, then sank by 141.46% to -$2.3 million in 2026.
- Business Quant data shows IBO's EBIT at -$2.3 million in Q1 2026, -$948000.0 in Q3 2025, and -$1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | -2.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.29 Mn |
| Sep 30, 2025 | -948,000.00 |
| Jun 30, 2025 | -1.15 Mn |
| Mar 31, 2025 | -1.01 Mn |
| Dec 31, 2024 | -26.23 Mn |
| Sep 30, 2024 | -1.13 Mn |
| Jun 30, 2024 | -626,000.00 |
| Mar 31, 2024 | -771,000.00 |
| Dec 31, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.08 Mn |
| Jun 30, 2023 | -1.01 Mn |
| Mar 31, 2023 | -803,000.00 |
| Dec 31, 2022 | -1.03 Mn |
| Sep 30, 2022 | -889,000.00 |
| Jun 30, 2022 | -750,000.00 |